Logo image of DSGX

DESCARTES SYSTEMS GRP/THE (DSGX) Stock Fundamental Analysis

USA - NASDAQ:DSGX - CA2499061083 - Common Stock

95.93 USD
-0.35 (-0.36%)
Last: 10/20/2025, 8:00:01 PM
95.93 USD
0 (0%)
After Hours: 10/20/2025, 8:00:01 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to DSGX. DSGX was compared to 285 industry peers in the Software industry. DSGX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. DSGX is growing strongly while it is still valued neutral. This is a good combination! These ratings could make DSGX a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

DSGX had positive earnings in the past year.
DSGX had a positive operating cash flow in the past year.
In the past 5 years DSGX has always been profitable.
In the past 5 years DSGX always reported a positive cash flow from operatings.
DSGX Yearly Net Income VS EBIT VS OCF VS FCFDSGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

1.2 Ratios

DSGX's Return On Assets of 8.44% is amongst the best of the industry. DSGX outperforms 83.51% of its industry peers.
DSGX has a better Return On Equity (9.88%) than 77.19% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.18%, DSGX belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DSGX is below the industry average of 11.90%.
The 3 year average ROIC (8.86%) for DSGX is below the current ROIC(9.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.44%
ROE 9.88%
ROIC 9.18%
ROA(3y)8.11%
ROA(5y)7.3%
ROE(3y)9.67%
ROE(5y)8.67%
ROIC(3y)8.86%
ROIC(5y)7.93%
DSGX Yearly ROA, ROE, ROICDSGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

DSGX has a Profit Margin of 21.64%. This is amongst the best in the industry. DSGX outperforms 87.02% of its industry peers.
In the last couple of years the Profit Margin of DSGX has grown nicely.
The Operating Margin of DSGX (27.33%) is better than 90.88% of its industry peers.
DSGX's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 76.06%, DSGX is doing good in the industry, outperforming 70.53% of the companies in the same industry.
DSGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.33%
PM (TTM) 21.64%
GM 76.06%
OM growth 3Y3.87%
OM growth 5Y11.08%
PM growth 3Y2.7%
PM growth 5Y14.15%
GM growth 3Y-0.17%
GM growth 5Y0.52%
DSGX Yearly Profit, Operating, Gross MarginsDSGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DSGX is destroying value.
DSGX has more shares outstanding than it did 1 year ago.
DSGX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for DSGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DSGX Yearly Shares OutstandingDSGX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
DSGX Yearly Total Debt VS Total AssetsDSGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

DSGX has an Altman-Z score of 20.50. This indicates that DSGX is financially healthy and has little risk of bankruptcy at the moment.
DSGX has a better Altman-Z score (20.50) than 94.04% of its industry peers.
DSGX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.5
ROIC/WACC0.9
WACC10.23%
DSGX Yearly LT Debt VS Equity VS FCFDSGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

DSGX has a Current Ratio of 1.70. This is a normal value and indicates that DSGX is financially healthy and should not expect problems in meeting its short term obligations.
DSGX has a Current ratio (1.70) which is in line with its industry peers.
DSGX has a Quick Ratio of 1.70. This is a normal value and indicates that DSGX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.70, DSGX perfoms like the industry average, outperforming 55.09% of the companies in the same industry.
DSGX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
DSGX Yearly Current Assets VS Current LiabilitesDSGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

7

3. Growth

3.1 Past

DSGX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.19%, which is quite good.
DSGX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.86% yearly.
Looking at the last year, DSGX shows a quite strong growth in Revenue. The Revenue has grown by 12.68% in the last year.
The Revenue has been growing by 14.85% on average over the past years. This is quite good.
EPS 1Y (TTM)14.19%
EPS 3Y18.17%
EPS 5Y30.86%
EPS Q2Q%7.5%
Revenue 1Y (TTM)12.68%
Revenue growth 3Y15.3%
Revenue growth 5Y14.85%
Sales Q2Q%10.05%

3.2 Future

The Earnings Per Share is expected to grow by 21.92% on average over the next years. This is a very strong growth
Based on estimates for the next years, DSGX will show a quite strong growth in Revenue. The Revenue will grow by 10.60% on average per year.
EPS Next Y11.02%
EPS Next 2Y29.89%
EPS Next 3Y24.27%
EPS Next 5Y21.92%
Revenue Next Year10.19%
Revenue Next 2Y11.81%
Revenue Next 3Y10.27%
Revenue Next 5Y10.6%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DSGX Yearly Revenue VS EstimatesDSGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
DSGX Yearly EPS VS EstimatesDSGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 56.76, DSGX can be considered very expensive at the moment.
DSGX's Price/Earnings is on the same level as the industry average.
DSGX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.69.
A Price/Forward Earnings ratio of 34.46 indicates a quite expensive valuation of DSGX.
The rest of the industry has a similar Price/Forward Earnings ratio as DSGX.
When comparing the Price/Forward Earnings ratio of DSGX to the average of the S&P500 Index (23.18), we can say DSGX is valued slightly more expensively.
Industry RankSector Rank
PE 56.76
Fwd PE 34.46
DSGX Price Earnings VS Forward Price EarningsDSGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DSGX is valued a bit cheaper than 74.04% of the companies in the same industry.
DSGX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DSGX is cheaper than 69.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 35.64
EV/EBITDA 29.7
DSGX Per share dataDSGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DSGX does not grow enough to justify the current Price/Earnings ratio.
DSGX has an outstanding profitability rating, which may justify a higher PE ratio.
DSGX's earnings are expected to grow with 24.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.15
PEG (5Y)1.84
EPS Next 2Y29.89%
EPS Next 3Y24.27%

0

5. Dividend

5.1 Amount

No dividends for DSGX!.
Industry RankSector Rank
Dividend Yield N/A

DESCARTES SYSTEMS GRP/THE

NASDAQ:DSGX (10/20/2025, 8:00:01 PM)

After market: 95.93 0 (0%)

95.93

-0.35 (-0.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-03 2025-09-03/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners92.55%
Inst Owner Change-0.33%
Ins Owners0.26%
Ins Owner ChangeN/A
Market Cap8.24B
Analysts77.78
Price Target98.8 (2.99%)
Short Float %0.82%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.34%
Min EPS beat(2)-6.83%
Max EPS beat(2)-1.85%
EPS beat(4)2
Avg EPS beat(4)-1.34%
Min EPS beat(4)-6.83%
Max EPS beat(4)2.86%
EPS beat(8)4
Avg EPS beat(8)-1.75%
EPS beat(12)7
Avg EPS beat(12)0.74%
EPS beat(16)9
Avg EPS beat(16)0.6%
Revenue beat(2)1
Avg Revenue beat(2)-0.24%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)1.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.27%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.1%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)7
Avg Revenue beat(12)-0.19%
Revenue beat(16)11
Avg Revenue beat(16)0.38%
PT rev (1m)-0.79%
PT rev (3m)-1.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.52%
EPS NY rev (1m)-2.47%
EPS NY rev (3m)-5.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 56.76
Fwd PE 34.46
P/S 12.04
P/FCF 35.64
P/OCF 34.67
P/B 5.5
P/tB 52.39
EV/EBITDA 29.7
EPS(TTM)1.69
EY1.76%
EPS(NY)2.78
Fwd EY2.9%
FCF(TTM)2.69
FCFY2.81%
OCF(TTM)2.77
OCFY2.88%
SpS7.97
BVpS17.45
TBVpS1.83
PEG (NY)5.15
PEG (5Y)1.84
Profitability
Industry RankSector Rank
ROA 8.44%
ROE 9.88%
ROCE 12.12%
ROIC 9.18%
ROICexc 10.87%
ROICexgc N/A
OM 27.33%
PM (TTM) 21.64%
GM 76.06%
FCFM 33.78%
ROA(3y)8.11%
ROA(5y)7.3%
ROE(3y)9.67%
ROE(5y)8.67%
ROIC(3y)8.86%
ROIC(5y)7.93%
ROICexc(3y)11.36%
ROICexc(5y)9.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.7%
ROCE(5y)10.48%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y6.45%
ROICexc growth 5Y18.03%
OM growth 3Y3.87%
OM growth 5Y11.08%
PM growth 3Y2.7%
PM growth 5Y14.15%
GM growth 3Y-0.17%
GM growth 5Y0.52%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 7.9%
Cap/Sales 0.95%
Interest Coverage 250
Cash Conversion 88.24%
Profit Quality 156.09%
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z 20.5
F-Score7
WACC10.23%
ROIC/WACC0.9
Cap/Depr(3y)8.9%
Cap/Depr(5y)8.08%
Cap/Sales(3y)1.09%
Cap/Sales(5y)1.1%
Profit Quality(3y)168.32%
Profit Quality(5y)189.61%
High Growth Momentum
Growth
EPS 1Y (TTM)14.19%
EPS 3Y18.17%
EPS 5Y30.86%
EPS Q2Q%7.5%
EPS Next Y11.02%
EPS Next 2Y29.89%
EPS Next 3Y24.27%
EPS Next 5Y21.92%
Revenue 1Y (TTM)12.68%
Revenue growth 3Y15.3%
Revenue growth 5Y14.85%
Sales Q2Q%10.05%
Revenue Next Year10.19%
Revenue Next 2Y11.81%
Revenue Next 3Y10.27%
Revenue Next 5Y10.6%
EBIT growth 1Y21.74%
EBIT growth 3Y19.76%
EBIT growth 5Y27.58%
EBIT Next Year73.8%
EBIT Next 3Y29.84%
EBIT Next 5Y23.17%
FCF growth 1Y17.77%
FCF growth 3Y7.45%
FCF growth 5Y16.41%
OCF growth 1Y17.48%
OCF growth 3Y7.57%
OCF growth 5Y16.02%